These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 8367633)

  • 1. [Treatment of rheumatoid arthritis: current and future].
    Bentin J
    Rev Med Brux; 1993 Jun; 14(6):175-81. PubMed ID: 8367633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of rheumatoid arthritis (chronic polyarthritis)].
    Villiger PM; Stucki G
    Praxis (Bern 1994); 1996 Sep; 85(37):1102-7. PubMed ID: 8927885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of disease-modifying antirheumatic drugs (DMARDs) in the therapy of rheumatoid arthritis].
    Cervini C; Salaffi F; Peroni M
    Clin Ter; 1993 Jan; 142(1):3-18. PubMed ID: 8472508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
    Emery P; Luqmani R; Gordon C
    Br J Clin Pract; 1994; 48(2):82-6. PubMed ID: 7912952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of disease modifying antirheumatic drugs.
    Harth M
    J Rheumatol Suppl; 1992 Jan; 32():100-3. PubMed ID: 1613728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-modifying agents and experimental treatments of rheumatoid arthritis.
    Weinblatt ME; Maier AL
    Clin Orthop Relat Res; 1991 Apr; (265):103-15. PubMed ID: 2009648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term drug treatment of chronic polyarthritis: current status and perspectives].
    Wollenhaupt J; Langer HE
    Wien Med Wochenschr; 1990 Jun; 140(12):324-33. PubMed ID: 2204217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status of drug therapy in chronic polyarthritis].
    Seitz M
    Ther Umsch; 1991 Sep; 48(9):613-23. PubMed ID: 1683020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is a disease modifying antirheumatic drug?
    Hepburn B
    J Rheumatol Suppl; 1988 Sep; 16():40-2. PubMed ID: 2903926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH; Whelton A
    Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rheumatoid arthritis. Considerations on a rational therapeutic strategy].
    Tarocco RP; Faro G; Michelotti A; Sargiotto A
    Minerva Med; 1984 Feb; 75(8):363-74. PubMed ID: 6369174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy.
    Fries JF; Williams CA; Singh G; Ramey DR
    J Rheumatol; 1997 May; 24(5):838-44. PubMed ID: 9150069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From aspirin to biologics: therapeutic implications for rheumatoid arthritis.
    Wright V
    J Rheumatol Suppl; 1992 Jan; 32():95-7. PubMed ID: 1613740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging the pyramid. A new look at terapeutic approaches for rheumatoid arthritis. Patient selection.
    Katz WA
    J Rheumatol Suppl; 1990 Nov; 25():39-41. PubMed ID: 1980315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern treatment of rheumatoid arthritis].
    Surányi P
    Orv Hetil; 2005 Oct; 146(40):2059-65. PubMed ID: 16259334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.